Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.

Diabetes Obes Metab · 2016 · PMC5129521 · PMID 27377054

Europe PMC DOI

hedged sentences

0.0640

closest p · 1.3× alpha

0.0770

boldest claim

The sentences

a strong trendp = .064so close (0.05 < p ≤ 0.1)

Nevertheless, MEDI0382‐treated mice exhibited significantly lower mean 24 hours RER relative to vehicle controls (p < .05), with a strong trend apparent when compared to pair‐fed mice (p = .064; Figure 5 E).

also in 5,725 other papers

did not quite reach statistical significancep = .077so close (0.05 < p ≤ 0.1)

Mean 24 hours VO 2 was significantly higher (by 22%, p < .05) relative to vehicle controls, but did not quite reach statistical significance compared to pair‐fed controls (15% increase, p = .077, Figure 5 C).

also in 679 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.